Senior Director, GMAT Lead - Early Pipeline

Join a Legacy of Innovation 125 Years and Counting! Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology.

Before applying for this role, please read the following information about this opportunity found below.

With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people.

In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

Summary Medical Affairs leader for the portfolio of early asset compounds under the supervision and leadership of the Global Medical Affairs (GMA) Franchise Head.

Develops the GMA early strategy and tactical plan and leads the execution of the activities in the GMA plan.

Responsibilities

• Responsible for the development of the Global Medical Affairs early strategy and medical objectives for the portfolio of early asset compounds and leads development, execution of the Global Medical Affairs plan and budget management including activities related to evidence generation, scientific engagement and communication
• Serves as Global Medical Affairs Team (GMAT) Lead, to gain strategic and planning alignment across the matrix team consisting of regional medical affairs and core GMA functions.

Represents medical affairs function as a member of the various cross-functional forums including, Publications Planning, Clinical and Safety sub-teams, and Global Product Team to inform clinical development, commercialization, market access, and other cross-functional strategic discussions.

Lead the team with sleeves rolled up, model the way and enable the team to act.Provides medical leadership to :

Partners with RWE strategy and Biomarker / CDx leads on related integrated evidence generation strategies and activities as part of the GMA Plan.

Provides medical review of expanded access programs (EAP) and, investigator-initiated studies (IIS) as part of a Global IIS Review Committee, for the portfolio of early asset compounds.

Leads internal stakeholder medical education activities related to the compound data.

In partnership with Medical Intelligence and Congress Planning leads, communicates and educates on related competitor data.

Provides medical support for scientific symposium and medical congresses within legal and compliance regulations.

Reviews and approves abstracts, manuscripts, and other data disclosure documents.

Education Qualifications (from an accredited college or university)

GMAT) and representing medical on cross-functional leadership teams (e.g.

Global Product Team, Global Brand Team, etc.)

is an equal opportunity / affirmative action employer.

Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.

Salary Range : $230,175.00